Pfizer Inc. is threatening legal action at an attempt by Novo Nordisk A/S is to scupper its acquisition of Metsera Inc ., with an unsolicited $9 billion offer for the anti-obesity specialist.
That trumps Pfizer’s agreed bid made in September, which valued... See more
Nephrology Climb Bio reports NHP data with CLYM-116 Sep. 30, 2025 No Comments Climb Bio Inc. has announced results from a completed nonhuman primate (NHP) study of CLYM-116, an anti-APRIL monoclonal antibody (mAb) in development for IgA nephropathy. Read ... See more
Dermatologic GS-6791 shows promise in murine dermatitis model Sep. 30, 2025 No Comments Interleukin-1 receptor-associated kinase 4 (IRAK-4) is a modulator of IL-1 receptor and Toll-like receptor (TLR) signaling and has emerged as a promising therapeutic t... See more
